CDK9-IN-19
CDK9-IN-19 is a potent and selective CDK9 inhibitor (IC50 = 2.0 nM) with anti-proliferative activity in cancer cells. It demonstrates efficacy in MV4-11 xenograft models and is a research tool for studying acute myeloid leukemia (AML), offering moderate PK properties and low hERG liability.
Product Specifications
CAS Number
2479306-60-8
Field of Research
Cell Biology, Epigenetics & Chromatin
Smiles
C (C) (=O) C1=C (C=2C (=CC (NC=3N=C (C (F) =CN3) C4=C (OC) C=C (F) C=C4) =CC2) OC1=O) N5CCOCC5
Molecular Formula
C26H22F2N4O5
Molecular Weight
508.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr7696-500gEcoli 500 µg (E. coli)
Recombinant Streptococcus Mutans pgk Protein (aa 1-398)
Sign In for Pricing
View Details 
E53A02729 50 µg
KIR2DL3 (p58 KIR, CD158), Human, Recombinant, Recombinant, E.coli
Sign In for Pricing
View Details ABIG-AGA-1 1.0 mL Bed Volume
Chicken anti Bovine IgG (H+L), conjugated with Agarose
Sign In for Pricing
View Details